Christopher A. Lipinski developed the rule in 1997 based on his observation that the majority of medications taken by mouth are made up of tiny, moderately lipophilic molecules ). Lipinski's rule of five is a rule of thumb for figuring out if a chemical compound with a certain pharmacological or biological activity has chemical and physical properties that make it likely to be an orally active drug in humans.